A Review of Therapeutic Aptamer Conjugates with Emphasis on New Approaches

被引:85
作者
Bruno, John G. [1 ]
机构
[1] Operat Technol Corp, 4100 NW Loop 410,Suite 230, San Antonio, TX 78229 USA
关键词
antibiotic-resistant; aptamer; cancer; complement; DNA; nanoparticle; opsonization; PCR; SELEX; siRNA;
D O I
10.3390/ph6030340
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The potential to emulate or enhance antibodies with nucleic acid aptamers while lowering costs has prompted development of new aptamer-protein, siRNA, drug, and nanoparticle conjugates. Specific focal points of this review discuss DNA aptamers covalently bound at their 3' ends to various proteins for enhanced stability and greater pharmacokinetic lifetimes in vivo. The proteins can include Fc tails of IgG for opsonization, and the first component of complement (C1q) to trigger complement-mediated lysis of antibiotic-resistant Gram negative bacteria, cancer cells and possibly some parasites during vulnerable stages. In addition, the 3' protein adduct may be a biotoxin, enzyme, or may simply be human serum albumin (HSA) or a drug known to bind HSA, thereby retarding kidney and other organ clearance and inhibiting serum exonucleases. In this review, the author summarizes existing therapeutic aptamer conjugate categories and describes his patented concept for PCR-based amplification of double-stranded aptamers followed by covalent attachment of proteins or other agents to the chemically vulnerable overhanging 3' adenine added by Taq polymerase. PCR amplification of aptamers could dramatically lower the current $2,000/gram cost of parallel chemical oligonucleotide synthesis, thereby enabling mass production of aptamer-3'-protein or drug conjugates to better compete against expensive humanized monoclonal antibodies.
引用
收藏
页码:340 / 357
页数:18
相关论文
共 117 条
[1]   THE BINDING OF IBUPROFEN TO PLASMA-PROTEINS [J].
AARONS, L ;
GRENNAN, DM ;
SIDDIQUI, M .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 25 (06) :815-818
[2]   An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform [J].
Bagalkot, Vaishali ;
Farokhzad, Omid C. ;
Langer, Robert ;
Jon, Sangyong .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2006, 45 (48) :8149-8152
[3]   Quantum dots as photosensitizers? [J].
Bakalova, R ;
Ohba, H ;
Zhelev, Z ;
Ishikawa, M ;
Baba, Y .
NATURE BIOTECHNOLOGY, 2004, 22 (11) :1360-1361
[4]   Gold Nano-Popcorn Attached SWCNT Hybrid Nanomaterial for Targeted Diagnosis and Photothermal Therapy of Human Breast Cancer Cells [J].
Beqa, Lule ;
Fan, Zhen ;
Singh, Anant Kumar ;
Senapati, Dulal ;
Ray, Paresh Chandra .
ACS APPLIED MATERIALS & INTERFACES, 2011, 3 (09) :3316-3324
[5]   Thermal Stability of siRNA Modulates Aptamer-conjugated siRNA Inhibition [J].
Berezhnoy, Alexey ;
Brenneman, Randall ;
Bajgelman, Marcio ;
Seales, Dawn ;
Gilboa, Eli .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2012, 1 :e51
[6]   Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer [J].
Bolhassani, Azam .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2011, 1816 (02) :232-246
[7]   Conjugation to polyethylene glycol polymer promotes aptamer biodistribution to healthy and inflamed tissues [J].
Boomer, RM ;
Lewis, SD ;
Healy, JM ;
Kurz, M ;
Wilson, C ;
McCauley, TG .
OLIGONUCLEOTIDES, 2005, 15 (03) :183-195
[8]   Design and synthesis of mono- and multimeric targeted radiopharmaceuticals based on novel cyclen ligands coupled to Anti-MUC1 aptamers for the diagnostic imaging and targeted radiotherapy of cancer [J].
Borbas, K. Eszter ;
Ferreira, Catia S. M. ;
Perkins, Alan ;
Bruce, James I. ;
Missailidis, Sotiris .
BIOCONJUGATE CHEMISTRY, 2007, 18 (04) :1205-1212
[9]   Chitosan nanoparticles for oral drug and gene delivery [J].
Bowman, Katherine ;
Leong, Kam W. .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2006, 1 (02) :117-128
[10]   In Vitro antibacterial effects of antilipopolysaccharide DNA aptamer-C1qrs complexes [J].
Bruno, J. G. ;
Carrillo, M. P. ;
Phillips, T. .
FOLIA MICROBIOLOGICA, 2008, 53 (04) :295-302